Researchers have shown, for the first time, how the genetic material of the Nipah virus replicates in infected cells. The ...

Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir ...

A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...

Targeted molecular interventions in the replication cycle and the immune recognition of viruses are intended to prevent viral entry into cells and ...

Oncolytics Biotech faces financial struggles and unclear pelareorep efficacy signals. Learn why ONCY stock's risks outweigh ...

ICMR-NIV director discusses India's expanding VRDL network, vaccine manufacturing, viral disease surveillance, and One Health ...

The CDC has sequenced bird flu viruses from people in Nevada and Wyoming, and the Trump Administration has released a ...

Chronic hepatitis B (CHB) remains a major global health challenge, with functional cure achieved in only a small subset of patients. Current oral antiviral agents effectively suppress viral ...

Antiviral treatments strive to block a virus or halt its replication. However, viruses are dynamic -- constantly evolving and changing shape, which can make designing antiviral treatments a challenge.

Q4 2024 Earnings Call Transcript March 11, 2025 Operator: Welcome to the SIGA Business Update Call. Before we turn the call ...